The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats
Open accessAbstract
Cachexia is the loss of lean body mass (LBM) that affects a large proportion of dogs and cats with congestive heart failure (CHF), chronic kidney disease (CKD), cancer, and a variety of other chronic diseases. Sarcopenia, the loss of LBM that occurs with aging, is a related syndrome, although sarcopenia occurs in the absence of disease. As many of the diseases associated with muscle loss are more common in aging, cachexia and sarcopenia often are concurrent problems. Both cachexia and sarcopenia have important clinical implications because they are associated with increased morbidity and mortality. The pathophysiology of these 2 syndromes is complex and multifactorial, but recent studies have provided new information that has helped to clarify mechanisms and identify potential new targets for treatment. Newly identified mechanisms and pathways that mediate cachexia appear to act by increasing energy requirements, decreasing energy intake, impairing nutrient absorption, and causing metabolic alterations. Whereas cachexia and sarcopenia are important areas of research for drug development in people, they are only beginning to be recognized in veterinary medicine. Greater awareness and earlier diagnosis will help provide practical approaches to managing body weight and lean tissue in dogs and cats, as well as more directed targets for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · cited 2×
“TNF and IL-1 also cause cardiac myocyte hypertrophy and fibrosis and have negative inotropic effects that may contribute to progression of the underlying disease.(73,74) Their mechanism appears to be primarily through the nuclear factor-jB (NF-jB) pathway, which has numerous effects, including increased muscle proteol…”
BackgroundDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P. (2005) · Circulation · doi:10.1161/circulationaha.104.530972 · Cited by 605
Influence of Resistance Exercise on Lean Body Mass in Aging Adults: A Meta-Analysis
PETERSON, M. D., SEN, A., & GORDON, P. M. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eb6265 · Cited by 558
Research works printed but not linked: 120
- Doehner, 2002, Cardiac cachexia in early literature: A review of research prior to Medline, Int J Cardiol, 85, 7, 10.1016/S0167-5273(02)00230-9 · DOI
- von Haehling, 2009, Cardiac cachexia: A systematic overview, Pharmacol Therapeut, 121, 227, 10.1016/j.pharmthera.2008.09.009 · DOI · Paper page
- Morley, 2006, Cachexia: Pathophysiology and clinical relevance, Am J Clin Nutr, 83, 735, 10.1093/ajcn/83.4.735 · DOI · Paper page
- Lowry, 2006, Modern Nutrition in Health and Disease, 1381
- Anker, 1997, Wasting as independent risk factor for mortality in chronic heart failure, Lancet, 349, 1050, 10.1016/S0140-6736(96)07015-8 · DOI · Paper page
- Anker, 2003, Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study, Lancet, 361, 1077, 10.1016/S0140-6736(03)12892-9 · DOI · Paper page
- Freeman, 1994, The nutrition implications of cardiac cachexia, Nutr Rev, 52, 340, 10.1111/j.1753-4887.1994.tb01358.x · DOI · Paper page
- Baez, 2007, A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients, J Fel Med Surg, 9, 411, 10.1016/j.jfms.2007.02.005 · DOI
- Scarlett, 1998, Associations between body condition and disease in cats, J Am Vet Med Assoc, 212, 1725, 10.2460/javma.1998.212.11.1725 · DOI · Paper page
- Doria-Rose, 2000, Mortality rates and causes of death among emaciated cats, J Am Vet Med Assoc, 216, 347, 10.2460/javma.2000.216.347 · DOI
- Mallery, 1999, Factors contributing to the decision for euthanasia of dogs with congestive heart failure, J Am Vet Med Assoc, 214, 1201, 10.2460/javma.1999.214.08.1201 · doi:10.2460/javma.1999.214.08.1201
- Sullivan, 1990, Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure, Circulation, 81, 518, 10.1161/01.CIR.81.2.518 · DOI · Paper page
- Carvalho, 2010, Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy, J Mol Histol, 41, 81, 10.1007/s10735-010-9262-x · DOI
- Oreopoulos, 2010, Comparison of direct body composition assessment methods in patients with chronic heart failure, J Card Fail, 16, 867, 10.1016/j.cardfail.2010.06.416 · DOI
- Freeman, 1996, Letter to the editor, J Vet Intern Med, 10, 99, 10.1111/j.1939-1676.1996.tb02037.x · DOI
- Evans, 2008, Cachexia: A new definition, Clin Nutr, 27, 6, 10.1016/j.clnu.2008.06.013 · DOI · Paper page
- Fearon, 2011, Definition and classification of cancer cachexia: An international consensus, Lancet Oncol, 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- Swimmer, 2011, Evaluation of the 6-minute walk test in pet dogs, J Vet Intern Med, 25, 405, 10.1111/j.1939-1676.2011.0689.x · doi:10.1111/j.1939-1676.2011.0689.x
- Freeman, 1998, Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure, J Vet Intern Med, 12, 440, 10.1111/j.1939-1676.1998.tb02148.x · DOI
- Oreopoulos, 2008, Body mass index and mortality in heart failure: A meta-analysis, Am Heart J, 156, 13, 10.1016/j.ahj.2008.02.014 · DOI · Paper page
- Webster, 1984, The composition of excess weight in obese women estimated by body density, total body water and total body potassium, Hum Nutr Clin Nutr, 38, 299
- Wells, 2006, Body composition in normal weight, overweight and obese children: Matched case-control analyses of total and regional tissue masses, and body composition trends in relation to relative weight, Int J Obesity, 30, 1506, 10.1038/sj.ijo.0803402 · DOI
- Slupe, 2008, Association of body weight and body condition with survival in dogs with heart failure, J Vet Intern Med, 22, 561, 10.1111/j.1939-1676.2008.0071.x · DOI
- Finn, 2010, The relationship between body weight, body condition, and survival in cats with heart failure, J Vet Intern Med, 24, 1369, 10.1111/j.1939-1676.2010.0584.x · DOI
- Tisdale, 2009, Mechanisms of cancer cachexia, Physiol Rev, 89, 381, 10.1152/physrev.00016.2008 · DOI · Paper page
- Michel, 2004, Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service, J Vet Intern Med, 18, 692, 10.1111/j.1939-1676.2004.tb02607.x · DOI
- Weeth, 2007, Prevalence of obese dogs in a population of dogs with cancer, Am J Vet Res, 68, 389, 10.2460/ajvr.68.4.389 · DOI
- Laflamme, 1997, Development and validation of a body condition score system for dogs, Canine Pract, 22, 10
- Laflamme, 1997, Development and validation of a body condition score system for cats, Feline Pract, 25, 13
- Glanton, 2003, Factors associated with improved short term survival in obese end stage renal disease patients, Ann Epidemiol, 13, 136, 10.1016/S1047-2797(02)00251-X · DOI
- Fleischmann, 1999, Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients, Kidney Int, 55, 1560, 10.1046/j.1523-1755.1999.00389.x · DOI · Paper page
- Kovesdy, 2007, Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis, Am J Kidney Dis, 49, 581, 10.1053/j.ajkd.2007.02.277 · DOI · Paper page
- Kalantar-Zadeh, 2010, The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis, Mayo Clinic Proc, 85, 991, 10.4065/mcp.2010.0336 · DOI · Paper page
- Abbott, 2004, Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study, Kidney Int, 65, 597, 10.1111/j.1523-1755.2004.00385.x · DOI · Paper page
- Port, 2002, Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients, J Am Soc Nephrol, 13, 1061, 10.1681/ASN.V1341061 · DOI · Paper page
- Leavey, 1998, Simple nutritional indicators as independent predictors of mortality in hemodialysis patients, Am J Kidney Dis, 31, 997, 10.1053/ajkd.1998.v31.pm9631845 · DOI · Paper page
- Leavey, 2001, Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol Dial Transplant, 16, 2386, 10.1093/ndt/16.12.2386 · DOI · Paper page
- Wolfe, 2000, Body size, dose of hemodialysis, and mortality, Am J Kidney Dis, 35, 80, 10.1016/S0272-6386(00)70305-2 · DOI · Paper page
- Kopple, 1999, Body weight-for-height relationships predict mortality in maintenance hemodialysis patients, Kidney Int, 56, 1136, 10.1046/j.1523-1755.1999.00615.x · DOI · Paper page
- Johansen, 2004, Association of body size with outcomes among patients beginning dialysis, Am J Clin Nutr, 80, 324, 10.1093/ajcn/80.2.324 · DOI · Paper page
- Lowrie, 2002, Body size, dialysis dose and death risk relationships among hemodialysis patients, Kidney Int, 62, 1891, 10.1046/j.1523-1755.2002.00642.x · DOI
- Kaizu, 1998, Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients, Clin Nephrol, 50, 44
- Parker, Association between body condition and survival in dogs with acquired chronic kidney disease, 10.1111/j.1939-1676.2011.00805.x · DOI
- Escalante, 2005, Paradoxical effect of body mass index on survival in rheumatoid arthritis: Role of comorbidity and systemic inflammation, Arch Intern Med, 165, 1624, 10.1001/archinte.165.14.1624 · DOI · Paper page
- Roubenoff, 2009, Rheumatoid cachexia: A complication of rheumatoid arthritis moves into the 21st century, Arthritis Res Therapy, 11, 108, 10.1186/ar2658 · DOI
- Marti, 2006, Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy, Eur Resp J, 27, 689, 10.1183/09031936.06.00076405 · DOI
- Wanke, 2004, Collaborative recommendations: The approach to diagnosis and treatment of HIV wasting, JAIDS, 37, S284
- Biggs, 2010, Association between adiposity in midlife and older age and risk of diabetes in older adults, J Am Med Assoc, 303, 2504, 10.1001/jama.2010.843 · DOI
- Lang, 2009, Sarcopenia: Etiology, clinical consequences, intervention, and assessment, Osteoporosis Int, 21, 543, 10.1007/s00198-009-1059-y · DOI · Paper page
- Meyer, 1980, Nutrition of the Dog and Cat, 15
- Lawler, 2009, Diet restriction and ageing in the dog: Major observations over two decades, Br J Nutr, 99, 793, 10.1017/S0007114507871686 · DOI · Paper page
- Toth, 1997, Daily energy requirements in heart failure patients, Metabolism, 46, 1294, 10.1016/S0026-0495(97)90233-X · DOI
- Riley, 1991, Resting energy expenditure in chronic cardiac failure, Clin Sci, 80, 633, 10.1042/cs0800633 · DOI
- Ogilvie, 1996, Resting energy expenditure in dogs with nonhematopoietic malignancies before and after excision of tumors, Am J Vet Res, 57, 1463, 10.2460/ajvr.1996.57.10.1463 · DOI
- Freeman, 2003, Evaluation of dietary patterns in dogs with cardiac disease, J Am Vet Med Assoc, 223, 1301, 10.2460/javma.2003.223.1301 · doi:10.2460/javma.2003.223.1301
- Torin, 2007, Dietary patterns of cats with cardiac disease, J Am Vet Med Assoc, 230, 862, 10.2460/javma.230.6.862 · DOI
- Woods, 2008, Central control of body weight and appetite, J Clin Endocrinol Metab, 93, S37, 10.1210/jc.2008-1630 · DOI · Paper page
- Laviano, 2008, Neural control of the anorexia-cachexia syndrome, Am J Physiol Endocrinol Metab, 295, E1000, 10.1152/ajpendo.90252.2008 · DOI
- Schwenke, 2008, Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality, Endocrinology, 149, 5172, 10.1210/en.2008-0472 · DOI
- Deboer, 2008, Ghrelin treatment of chronic kidney disease: Improvements in lean body mass and cytokine profile, Endocrinology, 149, 827, 10.1210/en.2007-1046 · DOI
- DeBoer, 2008, Emergence of ghrelin as a treatment for cachexia syndromes, Nutrition, 24, 806, 10.1016/j.nut.2008.06.013 · DOI
- Lund, 2009, Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation, Eur J Heart Fail, 11, 789, 10.1093/eurjhf/hfp088 · DOI
- Nagaya, 2001, Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure, Circulation, 104, 1430, 10.1161/hc3601.095575 · DOI · Paper page
- Nagaya, 2004, Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure, Circulation, 110, 3674, 10.1161/01.CIR.0000149746.62908.BB · DOI · Paper page
- Akashi, 2009, No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure, Int J Cardiol, 137, 267, 10.1016/j.ijcard.2008.06.094 · DOI
- Nagaya, 2005, Treatment of cachexia with ghrelin in patients with COPD, Chest, 128, 1187, 10.1378/chest.128.3.1187 · DOI · Paper page
- Strassburg, 2008, Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats, Am J Physiol Endocrinol Metab, 295, E78, 10.1152/ajpendo.00040.2008 · DOI
- Hamid, 2009, Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation, Circulation, 119, 1386, 10.1161/CIRCULATIONAHA.108.802918 · DOI · Paper page
- Moresi, 2008, Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response, Stem Cells, 26, 997, 10.1634/stemcells.2007-0493 · DOI
- Anker, 2002, How to recover from renaissance? The significance of the results of recover, renaissance, renewal and attach, Int J Cardiol, 86, 123, 10.1016/S0167-5273(02)00470-9 · DOI · Paper page
- Marcora, 2006, Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis, Am J Clin Nutr, 84, 1463, 10.1093/ajcn/84.6.1463 · DOI · Paper page
- Wiese, 2008, Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy, Nutr Clin Pract, 23, 551, 10.1177/0884533608323421 · DOI
- Meurs, 2002, Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure, Am J Vet Res, 63, 640, 10.2460/ajvr.2002.63.640 · DOI
- Sheth, 2002, Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure, Am J Cardiol, 90, 496, 10.1016/S0002-9149(02)02521-3 · DOI
- Matsumori, 1997, Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: A possible mechanism for its effect in heart failure, Circulation, 96, 1386, 10.1161/01.CIR.96.5.1386 · DOI
- Parissis, 2004, Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure, Am J Cardiol, 93, 1309, 10.1016/j.amjcard.2004.01.073 · DOI · Paper page
- Molenaar, 2006, Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting, Br J Pharmacol, 147, 583, 10.1038/sj.bjp.0706670 · DOI
- Yu, 2008, Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli, PLoS ONE, 3, e2086, 10.1371/journal.pone.0002086 · DOI
- Lenk, 2009, Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model, Eur J Heart Fail, 11, 342, 10.1093/eurjhf/hfp020 · DOI
- McFarlane, 2006, Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism, J Cell Physiol, 209, 501, 10.1002/jcp.20757 · DOI · Paper page
- Gruson, 2011, Increased plasma myostatin in heart failure, Eur J Heart Fail, 13, 734, 10.1093/eurjhf/hfr024 · DOI
- Kambadur, 1997, Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle, Genome Res, 7, 910, 10.1101/gr.7.9.910 · DOI · Paper page
- Grobet, 1997, A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle, Nat Genet, 17, 71, 10.1038/ng0997-71 · DOI · Paper page
- Zimmers, 2002, Induction of cachexia in mice by systemically administered myostatin, Science, 296, 1486, 10.1126/science.1069525 · DOI · Paper page
- Benny Klimek, 2010, Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia, Biochem Biophys Res Comm, 391, 1548, 10.1016/j.bbrc.2009.12.123 · DOI · Paper page
- Zhou, 2010, Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival, Cell, 142, 531, 10.1016/j.cell.2010.07.011 · DOI · Paper page
- Whittemore, 2003, Inhibition of myostatin in adult mice increases skeletal muscle mass and strength, Biochem Biophys Res Comm, 300, 965, 10.1016/S0006-291X(02)02953-4 · DOI · Paper page
- Siriett, 2007, Antagonism of myostatin enhances muscle regeneration during sarcopenia, Mol Ther: J Am Soc Gene Ther, 15, 1463, 10.1038/sj.mt.6300182 · DOI
- Dalla Libera, 2010, Skeletal muscle proteins oxidation in chronic right heart failure in rats: Can different beta-blockers prevent it to the same degree?, Int J Cardiol, 143, 192, 10.1016/j.ijcard.2009.02.012 · DOI
- Hryniewicz, 2007, Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure, J Card Fail, 9, 464, 10.1016/S1071-9164(03)00582-7 · DOI
- Lainscak, 2006, Body composition changes in patients with systolic heart failure treated with beta blockers: A pilot study, Int J Cardiol, 106, 319, 10.1016/j.ijcard.2005.01.061 · DOI
- Vaz Perez, 2010, The relationship between tumor necrosis factor-alpha, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure, Int J Cardiol, 141, 39, 10.1016/j.ijcard.2008.11.146 · DOI
- McEntegart, 2007, Increase in serum adiponectin concentration in patients with heart failure and cachexia: Relationship with leptin, other cytokines, and B-type natriuretic peptide, Eur Heart J, 28, 829, 10.1093/eurheartj/ehm033 · DOI
- Lafontan, 2005, An unsuspected metabolic role for atrial natriuretic peptides: The control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans, Arterioscler Thromb Vasc Biol, 25, 2032, 10.1161/01.ATV.0000183728.14712.d8 · DOI
- Doehner, 2001, Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia, Eur J Endocrinol, 145, 727, 10.1530/eje.0.1450727 · DOI
- Fonfara, 2011, Leptin expression in dogs with cardiac disease and congestive heart failure, J Vet Intern Med, 25, 1017, 10.1111/j.1939-1676.2011.00782.x · DOI
- Laoutaris, 2009, High plasma adiponectin is related to low functional capacity in patients with chronic heart failure, Int J Cardiol, 144, 230, 10.1016/j.ijcard.2008.12.126 · DOI
- Wolf, 2006, Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients, Cancer, 106, 966, 10.1002/cncr.21690 · DOI · Paper page
- Smiechowska, 2010, Adipokines in patients with cancer anorexia and cachexia, J Invest Med, 58, 554, 10.2310/JIM.0b013e3181cf91ca · DOI
- Kerem, 2008, Adipokines and ghrelin in gastric cancer cachexia, World J Gastroenterol, 14, 3633, 10.3748/wjg.14.3633 · DOI
- Penna, 2010, Muscle atrophy in experimental cancer cachexia: Is the IGF-1 signaling pathway involved?, Int J Cancer, 127, 1706, 10.1002/ijc.25146 · DOI
- Petretta, 2007, NT-proBNP, IGF-I and survival in patients with chronic heart failure, Growth Horm IGF Res, 17, 288, 10.1016/j.ghir.2007.01.020 · DOI
- Gotherstrom, 2007, A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults, J Clin Endocrinol Metab, 92, 1442, 10.1210/jc.2006-1487 · DOI
- Rosenthal, 2002, Gene therapy for cardiac cachexia?, Int J Cardiol, 85, 185, 10.1016/S0167-5273(02)00253-X · DOI
- Rojas Vega, 2010, Effect of resistance exercise on serum levels of growth factors in humans, Horm Metab Res, 42, 982, 10.1055/s-0030-1267950 · DOI
- Fearon, 2008, Cancer cachexia: Developing multimodal therapy for a multidimensional problem, Eur J Cancer, 44, 1124, 10.1016/j.ejca.2008.02.033 · DOI · Paper page
- Baldwin, 2010, AAHA nutritional assessment guidelines for dogs and cats, J Am Anim Hosp Assoc, 46, 285, 10.5326/0460285 · DOI · Paper page
- WSAVA Nutritional Assessment Guidelines Task Force Members, 2011, Nutritional assessment guidelines, J Small Anim Pract, 52, 385, 10.1111/j.1748-5827.2011.01079.x · DOI · Paper page
- Buffington, Indoor pet initiative
- Association of American Feed Control Officials, 2011, Official Publication
- Hutchinson, 2011, Survey of opinions about nutritional requirements of senior dogs and analysis of nutrient profiles of commercially available diets for senior dogs, Int J Appl Res Vet Med, 9, 68
- Lana, 2006, The use of complementary and alternative therapies in dogs and cats with cancer, J Am Anim Hosp Assoc, 42, 361, 10.5326/0420361 · doi:10.5326/0420361
- American College of Veterinary Nutrition website
- Delaney, 2011, How a diplomate of the American College of Veterinary Nutrition can help your practice and patients, Compend Contin Educ Vet, 33, E1
- Smith, 2007, Omega-3 fatty acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy, J Vet Intern Med, 21, 265, 10.1111/j.1939-1676.2007.tb02959.x · doi:10.1111/j.1939-1676.2007.tb02959.x
- Freeman, 2010, Beneficial effects of omega-3 fatty acids in cardiovascular disease, J Small Anim Pract, 51, 462, 10.1111/j.1748-5827.2010.00968.x · DOI
- Bauer, 2007, Responses of dogs to dietary omega-3 fatty acids, J Am Vet Med Assoc, 231, 1657, 10.2460/javma.231.11.1657 · DOI
- Glover, 2010, Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy, Curr Opin Clin Nutr Metab Care, 13, 630
- Cheema, 2007, Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: The Progressive Exercise for Anabolism in Kidney Disease (PEAK) study, Am J Kid Dis, 50, 574, 10.1053/j.ajkd.2007.07.005 · DOI
- Schulze, 2002, Chronic heart failure and skeletal muscle catabolism: Effects of exercise training, Int J Cardiol, 85, 141, 10.1016/S0167-5273(02)00243-7 · DOI
Cited by
Keene, B. W., Atkins, C. E., Bonagura, J. D., Fox, P. R., Häggström, J., Fuentes, V. L., Oyama, M. A., Rush, J. E., Stepien, R., & Uechi, M. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15488 · Cited by 831
Animal models of aging research: implications for human aging and age-related diseases
Mitchell, S. J., Scheibye-Knudsen, M., Longo, D. L., & de Cabo, R. (2015) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-110829 · Cited by 328
2021 AAHA Nutrition and Weight Management Guidelines for Dogs and Cats
Cline, M. G., Burns, K. M., Coe, J. B., Downing, R., Durzi, T., Murphy, M., & Parker, V. (2021) · Journal of the American Animal Hospital Association · doi:10.5326/jaaha-ms-7232 · Cited by 107
Diet-associated dilated cardiomyopathy in dogs: what do we know?
Freeman, L. M., Stern, J. A., Fries, R., Adin, D. B., & Rush, J. E. (2018) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.253.11.1390 · Cited by 69
Self-citationFreeman, L. M., Michel, K. E., Zanghi, B. M., Vester Boler, B. M., & Fages, J. (2019) · American Journal of Veterinary Research · doi:10.2460/ajvr.80.6.595 · Cited by 53
Self-citation
Metadata
- Authors
- Freeman, L. M.
- Venue
- Journal of Veterinary Internal Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 26
- Issue
- 1
- Pages
- 3-17
- ISSN
- 0891-6640 (ISSN-L)
- 1939-1676
- OpenAlex
- W2157868418
- Cited by
- 205
- References
- 15
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats. https://app.cochat.ai/papers/10.1111/j.1939-1676.2011.00838.x
- The paper
- Freeman, L. M. (2012). Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/j.1939-1676.2011.00838.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.